These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 26297729

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M, Chen Y, Huang H, Zhou X, Liu J, Huang G.
    Oncotarget; 2016 Dec 13; 7(50):83544-83553. PubMed ID: 27835875
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
    Yang DH, Min JJ, Song HC, Jeong YY, Chung WK, Bae SY, Ahn JS, Kim YK, Bom HS, Chung IJ, Kim HJ, Lee JJ.
    Eur J Cancer; 2011 Jun 13; 47(9):1312-8. PubMed ID: 21334197
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of bone marrow 2-[18F]-fluoro-2-deoxy-d-glucose uptake in diffuse large B-cell lymphoma: relation to iliac crest biopsy results.
    Lim CH, Hyun SH, Cho YS, Choi JY, Lee KH.
    Clin Radiol; 2021 Jul 13; 76(7):550.e19-550.e28. PubMed ID: 33762136
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma.
    Adams HJA, de Klerk JMH, Fijnheer R, Heggelman BGF, Dubois SV, Nievelstein RAJ, Kwee TC.
    Eur J Radiol; 2016 Jan 13; 85(1):304-309. PubMed ID: 26515992
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma.
    Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC.
    Clin Lymphoma Myeloma Leuk; 2015 Nov 13; 15(11):671-9. PubMed ID: 26361646
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.
    Adams HJ, Nievelstein RA, Kwee TC.
    Br J Haematol; 2015 Jul 13; 170(2):185-91. PubMed ID: 25833790
    [Abstract] [Full Text] [Related]

  • 14. Diffuse thyroid 18F-FDG uptake after R-CHOP therapy predicts favorable outcome in patients with DLBCL.
    Song MK, Chung JS, Kim SJ, Kim SS, Shin HJ.
    Ann Hematol; 2015 Jun 13; 94(6):995-1001. PubMed ID: 25687840
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of negative interim 2-[¹⁸F]-fluoro-2-deoxy-d-glucose PET/CT in diffuse large B-cell lymphoma.
    Kwon SH, Kang DR, Kim J, Yoon JK, Lee SJ, Jeong SH, Lee HW, An YS.
    Clin Radiol; 2016 Mar 13; 71(3):280-6. PubMed ID: 26732889
    [Abstract] [Full Text] [Related]

  • 18. Will Baseline Total Lesion Glycolysis Play a Role in Improving the Prognostic Value of the NCCN-IPI in Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated With the R-CHOP Regimen?
    Jiang C, Ding C, Xu J, Teng Y, Chen J, Wang Z, Zhou Z.
    Clin Nucl Med; 2021 Jan 13; 46(1):1-7. PubMed ID: 33181743
    [Abstract] [Full Text] [Related]

  • 19. Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.
    Chihara D, Oki Y, Ine S, Kato H, Onoda H, Taji H, Kagami Y, Yamamoto K, Morishima Y.
    Eur J Haematol; 2010 Jun 13; 84(6):493-8. PubMed ID: 20148943
    [Abstract] [Full Text] [Related]

  • 20. Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
    Lavi N, Shapira G, Zilberlicht A, Benyamini N, Farbstein D, Dann EJ, Bar-Shalom R, Avivi I.
    Isr Med Assoc J; 2016 Jul 13; 18(7):411-417. PubMed ID: 28471564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.